Copaxone-Teva

Copaxone-Teva: A drug for the treatment of multiple sclerosis

Copaxone-Teva is a drug used to treat relapsing-remitting multiple sclerosis. It is produced by the Israeli company Teva Pharmaceutical Enterprises Ltd. and belongs to the pharmacological group of drugs that stimulate immune processes.

The main active substance of the drug is glatiramer acetate. Copaxone-Teva is available in several dosage forms, including lyophilized powder for the preparation of an injection solution with a dosage of 20 mg, a lyophilized powder for the preparation of a solution for subcutaneous injection with a dosage of 20 mg, and a solution for subcutaneous injection with a concentration of 20 mg/ml.

Some side effects may occur when using Copaxone-Teva. This may include vasodilation, flushing, chest pain or heaviness, palpitations, increased blood pressure, restlessness, anxiety, weakness, shortness of breath, nausea, difficulty swallowing, arthralgia, lymphadenopathy, and urticaria. Local reactions may include soreness at the injection site, redness, swelling and itching.

Copaxone-Teva is compatible with glucocorticoids, however, it is always recommended to consult a doctor or pharmacist before starting treatment.

Before using Copaxone-Teva, it is important to pay attention to the special instructions. The first injection should be carried out under the supervision of a qualified specialist. If the prepared solution contains undissolved particles, its use is not recommended. The contents of the bottle are intended for single use only, and the remaining solution should be destroyed.

It is important to note that the data presented is based on information from the 2004 Encyclopedia of Drugs, and more current information may be available in newer sources.

Copaxone-Teva is an important pharmaceutical agent for the treatment of relapsing-remitting multiple sclerosis. However, before using it, you should consult your doctor and carefully study the instructions for use.